SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

   Biotech / MedicalImmucor


Previous 10 Next 10 
To: Mason Barge who wrote ()2/22/2000 4:20:00 PM
From: Thomas Kirwin
   of 422
 
Instant Replay - CNBC Interview of Ed Gallup on 2/22

CNBC interview of Mr. Gallup, Immucor Chairman & CEO, is now available via MS Media Player.

Follow the link below and enjoy the show...

cnbcdowjones.com

Best O'Luck!

Tom

Share RecommendKeepReplyMark as Last ReadRead Replies (1)


To: Thomas Kirwin who wrote (393)3/1/2000 6:52:00 PM
From: Thomas Kirwin
   of 422
 
CNBC Interview of Ed Gallup - Archive VOD

The CNBC interview of Ed Gallup may be played on demand. Simply follow the link below.

mktnews.nasdaq.com\\www\nasdaq\news\msnbc\2000\2\22\NASDAQ_1340_27090.htm&usymbol=BLUD&site=NASDAQ&sitesubtype=&logo=&companyname=

Best O'Luck!

Tom

Share RecommendKeepReplyMark as Last ReadRead Replies (1)


To: Thomas Kirwin who wrote (394)3/3/2000 8:25:00 AM
From: big guy
   of 422
 
Tom would you or anyone care to comment on this.

MTS manufactures a patented Gel Test which tests blood specimens to detect atypical antibodies which may affect transfusion or
impact pregnancy, thus reducing medical errors. MTS along with Stiftung Fur Diagnostische Forschung, a not-for-profit foundation
located in Switzerland, is continuing their patent infringement suit against U.S. based Immucor, Inc. (Nasdaq: BLUD) and its wholly
owned subsidiary, Gamma Biologicals, Inc.

I've just started following Immucor and ran across this. How big of a issue is it and does anyone have a idea of when and how it will be settled.

Thanks

Big Guy

Share RecommendKeepReplyMark as Last ReadRead Replies (2)


To: big guy who wrote (395)3/3/2000 9:05:00 AM
From: Thomas Kirwin
   of 422
 
ReACT vs LISS-AGT

Big Guy,

Welcome!

IMHO - The patent infringement claim does not have merit as the MTS Gel and ReACT systems arrive at the same results utilizing entirely different methods.

Might I suggest that you visit the Yahoo! Immucor BLUD Club Due-Diligence Web Site and read the report titled ReACT vs LISS-AGT in the "Photos" section to gain some insight regarding each system and their specific methods used.

clubs.yahoo.com

The lawsuit is still in the discovery phase to my knowledge. It should be decided in the courts sometime this year. IMHO there is no patent infringement!

ReACT has not contributed greatly to Immucor's bottom line thus far. Their automated instrument family is selling very well in the blood bank industry as well as hospitals.

Again, welcome!

Best O'Luck,

Tom

Share RecommendKeepReplyMark as Last ReadRead Replies (1)


To: Thomas Kirwin who wrote (396)3/3/2000 9:50:00 AM
From: big guy
   of 422
 
Thanks Tom I'll check it out.

Big Guy

Share RecommendKeepReplyMark as Last ReadRead Replies (1)


To: big guy who wrote (397)3/17/2000 12:57:00 PM
From: Thomas Kirwin
   of 422
 
Strong BUY Confirmed!

Blud Trackers,

See it for yourself - Strong BUY Rating for Immucor!

earnings.nasdaq-amex.com

nasdaq.com

Enter - BLUD

Best O'Luck,

Tom

P.S. I'm FREE!

Share RecommendKeepReplyMark as Last ReadRead Replies (1)


To: john.d who wrote (388)3/17/2000 1:01:00 PM
From: Thomas Kirwin
   of 422
 
We have a real analyst!

Blud Trackers,

NASDAQ Site Info Includes EPS Forcasts, etc....

Sidoti's EPS forcasts for Immucor and other information is available by clicking the following links on the NASDAQ site.

Recommendations | EPS | Earnings Surprise | Forecast | Momentum | P/E Ratio | Earnings Growth | P/E & Growth Rates | PEG Ratio

earnings.nasdaq-amex.com

We have a real analyst!

Best O'Luck,

Tom

Share RecommendKeepReplyMark as Last Read


To: big guy who wrote (395)3/25/2000 7:42:00 AM
From: Thomas Kirwin
   of 422
 
Alert - S&P Lists More Coverage

That's right folks!

The S&P Street Edition Report for Immucor lists the following as "Companies Offering Coverage".

Interstate Johnson Lane
Olde Discount
The Robinson Humphrey Co Inc

Best O'Luck,

Tom

Share RecommendKeepReplyMark as Last ReadRead Replies (2)


To: Thomas Kirwin who wrote (400)3/25/2000 7:43:00 AM
From: Thomas Kirwin
   of 422
 
Wall Street Courting BLUD

It's evident that "The Street" is courting Immucor with the issuance of Sidoti's BUY rating. Three other suitors are waiting in the wings. These distinguished grooms are Interstate Johnson Lane, Olde Discount and Robinson Humphrey. Only time will tell if a full blown love affair develops and ends with a trip to the alter.

Here comes the bride...da...da...da-da.

Best O'Luck,

Tom

Share RecommendKeepReplyMark as Last Read


To: Thomas Kirwin who wrote (400)3/25/2000 8:37:00 AM
From: big guy
   of 422
 
Thanks Tom,

I became a Blud brother Thursday when someone kindly sold me their shares for 11 5/8. Although were trading at the low end of the trading range the volume is light and I believe we won't be here for long. Hopefully this quarters numbers will be enough to get us though resistance in the fifteen area.

Take care

Big Guy

Share RecommendKeepReplyMark as Last ReadRead Replies (1)
Previous 10 Next 10